Telecom stocks are tumbling on news that SpaceX is aiming to secure 80,000 cell sites across the US, raising the specter of ...

Moderna and Merck’s cancer vaccine reduced the risk of melanoma recurrence or death by 42%, but investors questioned its ...

Tariff refunds boosted Tesla’s third-quarter numbers. Barring those, an analyst says, the EV maker would’ve missed across the ...

Bloom Energy reported 94 cents of earnings per share on $1.24 billion in revenue, beating expectations. The stock was sliding ...

Thursday evening, Newmont announced earnings per share of $2.20 from sales of $6.4 billion. Wall Street was looking for $1.96 ...

Western Digital’s pricing power and outlook will be in focus as investors assess whether the hard-drive market’s upswing can ...

Many state proposals are aimed at capping taxes, which could undercut the revenue that pays the interest and principal on ...

The prohibitions could cut off Big Pharma from Chinese biotechs—the source of many promising cancer treatments ...

Some investors are looking beyond turmoil in France for companies that depend little on their domestic market.

The stock market is reeling from the AI selloff and a Moderna data leak. High oil prices aren't helping, and more things to ...

SLB reported better-than-expected third-quarter earnings on Friday as its push into the artificial-intelligence data center ...

SpaceX stock is trying to end a wild week of trading in the green. An upgrade from Phillip Securities is helping.